PR Newswire (Mon, 8:00AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
GlobeNewswire (Apr 25, 2013)
-
-
GlobeNewswire (Apr 8, 2013)
-
GlobeNewswire (Mar 18, 2013)
-
GlobeNewswire (Mar 12, 2013)
-
IPO Market Update And OutlookIPO Candy • Wed, Jan 30 -
-
Intercept Pharmaceuticals: Strong Biopharmaceutical IPOThe Value Investor • Sun, Oct 14, 2012 -
IPO Preview: Intercept PharmaceuticalsIPOdesktop • Wed, Oct 10, 2012 -
Last Week In Global IPOs: Strong U.S. Deal Flow Set To ContinueJosef Schuster • Tue, Oct 9, 2012 -
To learn more about Seeking Alpha Pro, click here.
-
-
Intercept Pharmaceuticals: Strong Biopharmaceutical IPOThe Value Investor • Sun, Oct 14, 2012
-
IPO Preview: Intercept PharmaceuticalsIPOdesktop • Wed, Oct 10, 2012
-
GlobeNewswire (Apr 25, 2013)
-
GlobeNewswire (Apr 8, 2013)
-
GlobeNewswire (Mar 18, 2013)
-
GlobeNewswire (Mar 12, 2013)
-
at CNBC.com (Oct 11, 2012)
-
at MarketWatch.com (Oct 11, 2012)
-
at MarketWatch.com (Oct 11, 2012)
ICPT vs. ETF Alternatives
Company Description
ICPT is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver disease utilizing expertise in bile acid chemistry. ICPT product candidates have the potential to treat orphan and more prevalent liver diseases for which there... More